Ohba, S., Teranishi, T., Matsumura, K., Kumon, M., Kojima, D., Fujiwara, E., Nakao, K., Kuwahara, K., Murayama, K., Pareira, E. S., Yamada, S., Joko, M., Nakae, S., Muto, J., Nishiyama, Y., Adachi, K., Sasaki, H., Abe, M., Hasegawa, M., Hirose, Y. (2025). Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy. Scientific Reports. https://doi.org/10.1038/s41598-025-85339-x